Author

Mark Knappenberger

Arizona State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:multiome· 1 Research Focus:protein design· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Archana KiklaiD· 1 shared Erik PoppletoniD· 1 shared Karen S. AndersoniD· 1 shared Matthew Sample· 1 shared Michael P. GustafsoniD· 1 shared Nicholas StephanopoulosiD· 1 shared Olivia Roy· 1 shared Petr ŠulciD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Archana KiklaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered mRNA nanostructures expand the design space of mRNA therapeutics through programmable protein expression and immune stimulation

Mark Knappenberger, Skylar J.W. Henry, Archana Kikla, Matthew Sample, Olivia Roy, Erik Poppleton, Nicholas Stephanopoulos, Michael P. Gustafson, Karen S. Anderson, Petr Šulc

This paper introduces mRNA-OG, a programmable mRNA nanostructure that affects protein expression, delivery, and immune response through its architecture.

bioRxiv · Sep 17, 2026 · PreprintBioengineering